Retraction for: Circular RNA ZNF609 drives tumor progression by regulating the miR-138-5p/SIRT7 axis in melanoma
Quan Liu, Wei Cui, Chao Yang, Li-Ping Du
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsCircular RNAs in diseases · Nuclear Receptors and Signaling
This article has been retracted: Aging has completed its investigation of this paper. We found that four images in Figure 5F, 5G, which present the results of comet assays in A375 (5F) and SK-MEL-28 (5G) cells treated with control mimic or miR-138-5p mimic, or co-treated with miR-138-5p mimic and pcDNA3.1-SIRT7, were also used in Figure 3A, 3B, where cells were treated with circZNF609 shRNA or control shRNA. The same images were used again in Figure 4G, 4H, which show the results of comet assays in A375 and SK-MEL-28 cells treated with control shRNA or circZNF609 shRNA, or co-treated with circZNF609 shRNA and miR-138-5p inhibitor. The authors informed the journal that a portion of the original data is missing, so it is impossible to correct the misused images. All of the authors agreed to retract the manuscript and signed the retraction agreement letter.